Evotec SE (EVO) EBITDA Margin Growth (1y) (2010 - 2025)
Powered by 
Analysis
Evotec SE (EVO) EBITDA Margin Growth (1y) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | -101.00 |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | -38.00 |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 224.00 |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | -463.00 |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 4,868.00 |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | -14,185.00 |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | 1,247.00 |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | -5,330.00 |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | -744,940.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1,001.00 |
| Sep 30, 2025 | -1,283.00 |
| Jun 30, 2025 | -6,643.00 |
| Mar 31, 2025 | 498.00 |
| Dec 31, 2024 | 423.00 |
| Jun 30, 2024 | 6,720.00 |
| Dec 31, 2023 | -8.00 |
| Jun 30, 2023 | -1,480.00 |
| Dec 31, 2022 | 872.00 |
| Sep 30, 2022 | -1.11 Mn |
| Jun 30, 2022 | -330.00 |
| Mar 31, 2022 | -440.00 |
| Dec 31, 2021 | -1.00 |
| Sep 30, 2021 | -153,769.00 |
| Dec 31, 2020 | -1,511.00 |
| Jun 30, 2010 | 9,645.00 |
| Mar 31, 2010 | -26,078.00 |